Did The Market Already Bottom?
If Goldman Sachs is right, the market moves late last week were sufficient to alleviate selling pressure, at least for now. They identified a key line in the sand around 5250 where selling pressure would sharply drop over the coming week from the sell orders that had been slated.
It’s also been a tailwind to see big institutions, » Read more about: Did The Market Already Bottom? »
Read More
Alert: 17% Monthly Using Safe Strategy?
Investment Alert: Buy IONQ (IONQ) Sell Strike 13.50 Calls July 14 Expiration
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Forget AI,
» Read more about: Alert: 17% Monthly Using Safe Strategy? »
Read More
Market Commentary: Investing Book Sells for $4,542.24, Secrets Revealed
Seth Klarman is an investing icon, though many on Main Street don’t know his name. In 1991, he published a book called Margin of Safety that earned a place in Wall Street’s lore. As popular as the book became – reportedly even Warren Buffett owns a copy – it has been out of print…
Read More
Alert: Get Pharma Royalties Plus 58.1% Upside
Investment Alert: Buy Royalty Pharma (RPRX) Under $33/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
How would you like a cut of those lucrative pharmaceutical royalties that famously mint money?
» Read more about: Alert: Get Pharma Royalties Plus 58.1% Upside »
Read More
2x Champion Trader Goes SHORT
The wild statistics are flying now. At the depths of the price action on Friday, the bearish tape was as bad as any seen since the COVID lows.
2% corrections in the Dow Jones Industrial Average, NASDAQ and S&P 500 all signaled broad-based selling and the obliteration of just about every sector.
Nothing was left unscathed.
» Read more about: 2x Champion Trader Goes SHORT »
Read MoreThe Burst
Is It Time To Buy Chinese Stocks?
Chinese stocks have been beaten dow for a long time but it’s possible that a tectonic shift is taking place. It’s been such a puzzle to understand why their valuations have been low for such an extended time period that even the likes of Charlie Munger got fooled by cheap valuations.
One overarching challenge has been the ongoing regulatory environment.
» Read more about: Is It Time To Buy Chinese Stocks? »
Read MoreThe Spotlight
Spotlight: Will This Weed Stock Get Your Portfolio High?
Canopy Growth was at the forefront of the cannabis industry just a few years ago. But the Canadian cannabis producer has faced significant struggles that have reduced its valuation from billions to millions, as revenues have declined and losses have piled up.
In 2018, Canopy stock pushed past $50 per share, but investors have gradually given up on the stock since then.
» Read more about: Spotlight: Will This Weed Stock Get Your Portfolio High? »
Read MoreThe Daily
Stock Futures Rise to End Terrible February After S&P 500 Wipes Out 2025 Gains
It’s been a terrible February for the stock market.
The only crumb of comfort for investors is that it’s a short month and Friday is its final trading day. U.S. stock futures were pointing higher but Thursday’s selloff did real damage to the rally–wiping out the S&P 500’s gains in 2025 and sending the Nasdaq Composite close to correction territory.
» Read more about: Stock Futures Rise to End Terrible February After S&P 500 Wipes Out 2025 Gains »